MIRO Insider Trading Activity and SEC Form 4 Filings
MIRO insider trading summary
No open-market insider purchases or sales of Miromatrix Medical Inc. (MIRO) have been reported on SEC Form 4 in the past 12 months.
Latest MIRO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 10, 2023 | Paul Buckman | Insider | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | John L Erb | Insider | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | Jeffrey James Ross | Chief Executive Officer | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | Lisa Wipperman Heine | Insider | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | Peter Maag | Insider | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | William P. Mr. Burke | Insider | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | James Michael Douglas | Chief Financial Officer | Buy | $50K (31,250 @ $1.60) |
| Mar 10, 2023 | John Joseph Barry | Vice President of R&D | Buy | $10K (6,250 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.